HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.210

+0.0350.68%

Volume:3.98M

Turnover:21.03M

Market Cap:2.04B

PE:-9.47

High:5.375

Open:5.280

Low:5.185

Close:5.175

52wk High:77.000

52wk Low:4.940

Shares:391.00M

HK Float Shares:386.00M

Volume Ratio:1.64

T/O Rate:1.03%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.550

ROE:-125.57%

ROA:-44.55%

PB:6.54

PE(LYR):-9.47

PS:-152.35

Loading ...

Overview Company News Filings

PEGBIO CO-B Shares Surge Over 13% as CR059 Research Accepted for Presentation at EASD 2026

Movement Alert｜PegBio Pharma-B Rises 10.55% in Regular Trading, CR059 EASD Oral Presentation Selection and Buyback Plan Boost Sentiment

PegBio Sets 24 June 2026 for 2025 AGM; Capital Increase, Share Mandates and 2026 Budget on Ballot

Bulletin Express

PEGBIO's Innovative GLP-1 Analog CR059 Achieves Acceptance for Presentation at Prestigious EASD 2026 Conference

PegBio’s CR059 Gets EASD 2026 Oral Presentation Slot, Reinforcing Circular-RNA GLP-1 Leadership

Bulletin Express

PegBio says circular RNA-encoded GLP-1 candidate CR059 wins oral presentation slot at EASD 2026

PEGBIO CO-B's GLP-1 Agonist Vepetide Injection Included in 2026 National Reimbursement Drug List Pre-Communication Process

Stock Track | PegBio Pharma Soars 15.53% Intraday on Technical Rebound After IPO Lock-up Expiry Selloff

Movement Alert｜PegBio Pharma Rises 10.77% in Regular Trading, Technical Rebound After IPO Lock-up Expiry Selloff

Movement Alert｜PegBio Pharma Intraday Decline 15.99% in Regular Trading, Lock-Up Expiry on IPO Anniversary Triggers Selling Pressure

Stock Track | PegBio Soars 18.76% Intraday on Continued GLP-1 Drug Commercialization Momentum

Movement Alert｜PegBio Rises 7.54% in Regular Trading, Rebounding After Pullback as GLP-1 Drug Commercialization Momentum Continues

Stock Track | PegBio Plummets 6.96% Intraday Amid Lock-Up Expiry Concerns Following Partnership Rally

Movement Alert｜PegBio Falls 5.14% in Regular Trading, Pullback Continues Amid Lock-Up Expiry Concerns Following Multi-Day Rally

Stock Track | PegBio Soars 6.86% Intraday on GLP-1 Drug Commercialization Deals

Movement Alert｜PegBio Co Ltd Rises 8.37% in Regular Trading, Extending Gains on GLP-1 Drug Commercialization Momentum

PEGBIO CO-B Nominates Liao Yilin as Independent Non-Executive Director Candidate

Pegbio files directors list with Hong Kong Stock Exchange

PegBio: INED Resignation Triggers Temporary Rule Breach; New Candidate Nominated to Restore Compliance

Bulletin Express

PegBio independent director Fan resigns, audit committee chair role to change

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/02565/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"PEGBIO CO-B","latestPrice":5.21,"timestamp":1790755707004,"preClose":5.175,"halted":0,"volume":3981650,"delay":0,"changeRate":0.006763285024154617,"floatShares":386000000,"shares":391000000,"eps":-0.55,"marketStatus":"Closed National Day","change":0.035,"latestTime":"09-30 16:08:27","open":5.28,"high":5.375,"low":5.185,"amount":21028059,"amplitude":0.036715,"askPrice":5.215,"askSize":65350,"bidPrice":5.21,"bidSize":19250,"shortable":3,"etf":0,"ttmEps":-0.982664,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":5.175,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.642791422971399,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":386000000,"roa":"-44.55%","roe":"-125.57%","lyrEps":-0.55,"volumeRatio":1.642791422971399,"shares":391000000,"dividePrice":0,"high":5.375,"amplitude":0.036715,"preClose":5.175,"low":5.185,"week52Low":4.94,"pbRate":"6.54","psRate":"-152.35","week52High":77,"institutionHeld":0,"latestPrice":5.21,"committee":-0.544917,"eps":-0.55,"divideRate":0,"volume":3981650,"delay":0,"ttmEps":-0.982664,"open":5.28,"prevYearClose":69,"prevWeekClose":5.36,"prevMonthClose":5.21,"prevQuarterClose":5.21,"fiveDayClose":5.59,"twentyDayClose":5.585,"sixtyDayClose":5.52},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-09-30","current":-5.301914,"percent":0.993827,"low":-87.782868,"twenty":-72.093156,"median":-41.864246,"eighty":-10.258097,"high":-5.123552,"avg":-41.000092,"sd":28.902031,"marketCap":2037586881},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-29","current":-13.590249,"twenty":-73.716985,"median":-61.274827,"eighty":-19.064042,"marketCap":3375119921},{"date":"2026-06-05","current":-12.579887,"twenty":-73.438012,"median":-61.206433,"eighty":-18.597951,"marketCap":3128732256},{"date":"2026-06-12","current":-11.565594,"twenty":-73.352041,"median":-60.919795,"eighty":-17.056006,"marketCap":2874522760},{"date":"2026-06-18","current":-9.622776,"twenty":-73.31105,"median":-60.791238,"eighty":-14.753422,"marketCap":2397391091},{"date":"2026-06-26","current":-7.824338,"twenty":-73.278872,"median":-60.512398,"eighty":-13.899973,"marketCap":1939813998},{"date":"2026-07-03","current":-8.984958,"twenty":-73.271235,"median":-60.431019,"eighty":-13.561687,"marketCap":2229221732},{"date":"2026-07-10","current":-11.252888,"twenty":-73.25947,"median":-60.210807,"eighty":-13.050401,"marketCap":2788482623},{"date":"2026-07-17","current":-10.458113,"twenty":-73.235067,"median":-60.159469,"eighty":-12.830773,"marketCap":2600758687},{"date":"2026-07-24","current":-10.046967,"twenty":-73.215248,"median":-60.107782,"eighty":-12.739192,"marketCap":2499074889},{"date":"2026-07-31","current":-8.411523,"twenty":-73.183292,"median":-59.862622,"eighty":-12.522041,"marketCap":2096250611},{"date":"2026-08-07","current":-10.298244,"twenty":-73.061453,"median":-59.675079,"eighty":-12.306772,"marketCap":2571426822},{"date":"2026-08-14","current":-9.745542,"twenty":-72.966779,"median":-59.367669,"eighty":-11.991332,"marketCap":2436500244},{"date":"2026-08-21","current":-9.169953,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"marketCap":2297662750},{"date":"2026-08-28","current":-5.766342,"twenty":-72.790068,"median":-56.898206,"eighty":-11.368021,"marketCap":2225310817},{"date":"2026-09-04","current":-5.809614,"twenty":-72.647581,"median":-53.43223,"eighty":-11.296065,"marketCap":2242909936},{"date":"2026-09-11","current":-5.877658,"twenty":-72.523005,"median":-49.422967,"eighty":-11.223589,"marketCap":2272241800},{"date":"2026-09-18","current":-5.854834,"twenty":-72.380908,"median":-46.448991,"eighty":-11.082977,"marketCap":2266375427},{"date":"2026-09-25","current":-5.425683,"twenty":-72.097427,"median":-43.047517,"eighty":-10.604864,"marketCap":2096250611},{"date":"2026-09-30","current":-5.264024,"twenty":-72.093156,"median":-41.864246,"eighty":-10.258097,"marketCap":2037586881}],"updateTime":1790832689276},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142389682","title":"PEGBIO CO-B Shares Surge Over 13% as CR059 Research Accepted for Presentation at EASD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1142389682","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142389682?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:17","pubTimestamp":1780366627,"startTime":"0","endTime":"0","summary":"Shares of PEGBIO CO-B (HKEX: 02565) have surged more than 13%. At the time of writing, the stock is up 9.8% to HK$8.75, with a turnover of HK$108 million.The significant move follows a company...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","BK4588","BK4585","399441","02565","BK4581","XBI","BK1161","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185585479","title":"Movement Alert｜PegBio Pharma-B Rises 10.55% in Regular Trading, CR059 EASD Oral Presentation Selection and Buyback Plan Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1185585479","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185585479?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:05","pubTimestamp":1780365941,"startTime":"0","endTime":"0","summary":"On June 2, PegBio Pharma-B rose 10.55% in regular trading, trading at HK$8.75/share, with trading volume of HK$115 million.On the news front, the company released multiple positive catalysts in quick...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104725442","title":"PegBio Sets 24 June 2026 for 2025 AGM; Capital Increase, Share Mandates and 2026 Budget on Ballot","url":"https://stock-news.laohu8.com/highlight/detail?id=1104725442","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104725442?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:43","pubTimestamp":1780324997,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PEGBIO CO-B) has issued the formal proxy for its 2025 annual general meeting, to be convened at 10:00 a.m. (Hong Kong time) on 24 June 2026. The hybrid session will be physically...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154515574","title":"PEGBIO's Innovative GLP-1 Analog CR059 Achieves Acceptance for Presentation at Prestigious EASD 2026 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1154515574","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154515574?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:07","pubTimestamp":1780308430,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that its internally developed circular RNA-encoded GLP-1 analog, CR059, has had its research findings accepted for presentation at the 62nd European Association...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","161726","XBI","BK1161","399441","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150034110","title":"PegBio’s CR059 Gets EASD 2026 Oral Presentation Slot, Reinforcing Circular-RNA GLP-1 Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=1150034110","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150034110?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:05","pubTimestamp":1780308334,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PEGBIO CO-B, 02565) disclosed that its next-generation GLP-1 candidate, CR059, has been accepted for an oral discussion session at the 62nd Annual Meeting of the European...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640585689","title":"PegBio says circular RNA-encoded GLP-1 candidate CR059 wins oral presentation slot at EASD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640585689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640585689?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:02","pubTimestamp":1780308126,"startTime":"0","endTime":"0","summary":"PegBio disclosed June 1, 2026 that preclinical findings for CR059 were accepted for EASD 2026 and selected for an oral discussion session.The results were previously selected as a late-breaking abstract for the ADA Scientific Sessions; the EASD presentation is scheduled for 2026.A single dose in non-human primates supported sustained drug exposure and prolonged body-weight reduction, suggesting potential for ultra-long-acting dosing.The program uses circular RNA to drive in-body production of a GLP-1 analogue, positioning it as a differentiated approach versus peptide GLP-1 drugs.CR059 remains in R&D, with clinical development and commercialization still uncertain.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. publishe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL5zKjBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194812021","title":"PEGBIO CO-B's GLP-1 Agonist Vepetide Injection Included in 2026 National Reimbursement Drug List Pre-Communication Process","url":"https://stock-news.laohu8.com/highlight/detail?id=1194812021","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194812021?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:20","pubTimestamp":1779963627,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) announced that its Vepetide Injection has been included in the public notice for the second batch of 2026 reference drug pre-communication supplementary drugs, as published by the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4585","XBI","BK4588","399441","02565","161726","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155488745","title":"Stock Track | PegBio Pharma Soars 15.53% Intraday on Technical Rebound After IPO Lock-up Expiry Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1155488745","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155488745?lang=en_us&edition=fundamental","pubTime":"2026-05-28 09:34","pubTimestamp":1779932097,"startTime":"0","endTime":"0","summary":"PegBio Pharma's stock soared 15.53% during intraday trading on Thursday, marking a significant recovery in its share price.The sharp rise represents a technical rebound following a steep selloff in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111038713","title":"Movement Alert｜PegBio Pharma Rises 10.77% in Regular Trading, Technical Rebound After IPO Lock-up Expiry Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1111038713","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111038713?lang=en_us&edition=fundamental","pubTime":"2026-05-28 09:32","pubTimestamp":1779931937,"startTime":"0","endTime":"0","summary":"On May 28, PegBio Pharma (02565.HK) rose 10.77% in regular trading, trading at HK$10.1/share, with trading volume of HK$35.96 million.On the news front, the stock experienced a sharp technical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109340010","title":"Movement Alert｜PegBio Pharma Intraday Decline 15.99% in Regular Trading, Lock-Up Expiry on IPO Anniversary Triggers Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1109340010","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109340010?lang=en_us&edition=fundamental","pubTime":"2026-05-27 09:40","pubTimestamp":1779846006,"startTime":"0","endTime":"0","summary":"On May 27, PegBio Pharma (02565.HK) declined 15.99% in regular trading, trading at HK$8.78/share, with trading volume of HK$53.49 million.On the news front, May 27 marks the one-year anniversary of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107511918","title":"Stock Track | PegBio Soars 18.76% Intraday on Continued GLP-1 Drug Commercialization Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1107511918","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107511918?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:26","pubTimestamp":1779420405,"startTime":"0","endTime":"0","summary":"PegBio Co-B (02565.HK) experienced a significant intraday surge of 18.76%, continuing its recent volatile trading pattern.The stock's movement is driven by accelerating commercialization efforts for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106725922","title":"Movement Alert｜PegBio Rises 7.54% in Regular Trading, Rebounding After Pullback as GLP-1 Drug Commercialization Momentum Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1106725922","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106725922?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:25","pubTimestamp":1779420315,"startTime":"0","endTime":"0","summary":"On May 22, PegBio Co Ltd (02565.HK) rose 7.54% in regular trading, trading at HK$14.59/share with trading volume of HK$46.84 million, rebounding after a 5.14% decline in the prior session.The stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152383118","title":"Stock Track | PegBio Plummets 6.96% Intraday Amid Lock-Up Expiry Concerns Following Partnership Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1152383118","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152383118?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:07","pubTimestamp":1779329251,"startTime":"0","endTime":"0","summary":"PegBio Co-B (02565.HK) experienced a significant intraday plummet of 6.96%, continuing its recent pullback after an explosive rally earlier in the week. The decline is attributed to investor concerns...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162345639","title":"Movement Alert｜PegBio Falls 5.14% in Regular Trading, Pullback Continues Amid Lock-Up Expiry Concerns Following Multi-Day Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1162345639","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162345639?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:05","pubTimestamp":1779329149,"startTime":"0","endTime":"0","summary":"On May 21, PegBio Co Ltd (02565.HK) fell 5.14% in regular trading, trading at HK$14.38/share with trading volume of HK$29.44 million, extending a multi-day pullback after its explosive rally earlier...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161154336","title":"Stock Track | PegBio Soars 6.86% Intraday on GLP-1 Drug Commercialization Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=1161154336","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161154336?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:55","pubTimestamp":1779242132,"startTime":"0","endTime":"0","summary":"PegBio Co-B's stock was soaring 6.86% during intraday trading on Wednesday, extending a recent rally for the biopharmaceutical company.The sustained upward momentum is driven by the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191904835","title":"Movement Alert｜PegBio Co Ltd Rises 8.37% in Regular Trading, Extending Gains on GLP-1 Drug Commercialization Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1191904835","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191904835?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:52","pubTimestamp":1779241961,"startTime":"0","endTime":"0","summary":"On May 20, PegBio Co Ltd (02565.HK) rose 8.37% in regular trading, trading at HK$17.56/share with trading volume of HK$77.81 million, extending a multi-day rally following a surge of over 100% on May...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173460761","title":"PEGBIO CO-B Nominates Liao Yilin as Independent Non-Executive Director Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1173460761","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173460761?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:48","pubTimestamp":1779191319,"startTime":"0","endTime":"0","summary":"PEGBIO Co., Ltd. - B (02565) has announced that Ms. Fan Xinpeng has tendered her resignation as Independent Non-Executive Director, Chairman of the Board Audit Committee, and member of the Board...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","BK4588","BK4585","161726","BK1161","XBI","BK4581","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636558158","title":"Pegbio files directors list with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2636558158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636558158?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:48","pubTimestamp":1779191290,"startTime":"0","endTime":"0","summary":"PegBio filed an updated list of directors and board committee roles with the Hong Kong Stock Exchange dated May 19, 2026.Michael Min Xu remains chairman and an executive director, serving as chair of the Strategy and Development Committee.Committee leadership includes Jiancun Zhang as chair of the Remuneration and Appraisal Committee plus the Nomination Committee.Audit Committee membership includes Xiangjun Zhou plus Yangyang Chen.Other committee assignments include Xiaojun Wang on the Remuneration and Appraisal Committee, Xiangjun Zhou and Yuhong Xu on the Strategy and Development Committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. published the original content used to generate this news brief via IIS, the regul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL3sGZRy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176897551","title":"PegBio: INED Resignation Triggers Temporary Rule Breach; New Candidate Nominated to Restore Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1176897551","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176897551?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:44","pubTimestamp":1779191052,"startTime":"0","endTime":"0","summary":"On 19 May 2026, PegBio Co., Ltd. announced the resignation of Independent Non-Executive Director (INED) Ms. Xinpeng Fan, who also served as Chair of the Audit Committee and sat on both the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636385377","title":"PegBio independent director Fan resigns, audit committee chair role to change","url":"https://stock-news.laohu8.com/highlight/detail?id=2636385377","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636385377?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:41","pubTimestamp":1779190919,"startTime":"0","endTime":"0","summary":"PegBio disclosed the resignation of independent non-executive director Xinpeng Fan, effective May 19, 2026.Fan also stepped down as audit committee chair, with seats on the remuneration and appraisal committee, plus the nomination committee.The board nominated Liao Yik Lam as an independent non-executive director, pending shareholder approval at a general meeting.Liao is a partner at ZSZH  Fuson CPA Limited, with more than 20 years of experience in accounting, audit, company secretarial work, and business strategy.Upon election, Liao is set to take over as audit committee chair, with roles on the remuneration and appraisal committee and the nomination committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. published t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL1Zlxqy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":105,"code":"91000000","status":"200"}]}}